This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia
Nature Communications Open Access 01 September 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
von Schaper, E. Everything but amyloid: new thinking prompts FDA revamp. Nat Biotechnol 36, 483–484 (2018). https://doi.org/10.1038/nbt0618-483
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0618-483
This article is cited by
-
Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia
Nature Communications (2021)